CN103599271B - A kind of Chinese medicine for the treatment of hysteromyoma - Google Patents

A kind of Chinese medicine for the treatment of hysteromyoma Download PDF

Info

Publication number
CN103599271B
CN103599271B CN201310605613.3A CN201310605613A CN103599271B CN 103599271 B CN103599271 B CN 103599271B CN 201310605613 A CN201310605613 A CN 201310605613A CN 103599271 B CN103599271 B CN 103599271B
Authority
CN
China
Prior art keywords
parts
hysteromyoma
treatment
chinese medicine
folium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310605613.3A
Other languages
Chinese (zh)
Other versions
CN103599271A (en
Inventor
任新年
孙元盛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU GUILONG BIOLOGICAL TECHNIQUE Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310605613.3A priority Critical patent/CN103599271B/en
Publication of CN103599271A publication Critical patent/CN103599271A/en
Application granted granted Critical
Publication of CN103599271B publication Critical patent/CN103599271B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of Chinese medicine for the treatment of hysteromyoma, it is prepared from by the medical material of following weight proportion: Fructus Anisi Stellati 3 ~ 6 parts, Rhizoma Chuanxiong 3 ~ 10 parts, Concha Meretricis Seu Cyclinae 6 ~ 15 parts, Radix Bupleuri 3 ~ 10 parts, Medulla Junci 1 ~ 3 part, Flos Albiziae 5 ~ 10 parts, Folium Et Cacumen Murrayae 6 ~ 12 parts, Arillus Longan 9 ~ 15 parts, Flos Rosae Rugosae 3 ~ 6 parts, Fructus Ligustri Lucidi 6 ~ 12 parts.Experiment proves, the present invention can safe and effective treatment hysteromyoma.

Description

A kind of Chinese medicine for the treatment of hysteromyoma
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine for the treatment of hysteromyoma.
Background technology
Hysteromyoma is the modal a kind of tumors of female sex organs.Current pathogenic factor is still not clear, if but timely treatment can cause the harm such as female acyesis, miscarriage, frequent micturition, dysuria, and also can there is malignant change in minority, be a large killer of women's health.
Clinical manifestation is mainly: menoxenia, abdominal part swell companion bearing down, leucorrhea many and companion abnormal flavour, lower abdomen falling inflation, aching pain in waist and back etc.
Adopt excision at present, but excision one side somewhat expensive is painful large, only can excise established tumor on the one hand, can not improve the easy blastomogenic body constitution of patient, cannot effect a radical cure more.Medicine is hormones mainly, and the toxic and side effects of this kind of medicine is often difficult to expect, once occur to be difficult to again make up.Therefore the Chinese medicine researching and developing a kind of safe and effective treatment hysteromyoma is very with practical value.
Involved by Chinese medicine of the present invention, the present Research of medical material is as follows:
Fructus Anisi Stellati, this product is the dry mature fruit of Magnoliacea plant Fructus Anisi Stellati IlliciumverumHook.f..[nature and flavor with return through] are pungent, temperature.Return liver,kidney,spleen, stomach warp.[function with cure mainly] warming YANG to expel cold, regulating QI to relieve pain.For colic of cold type stomachache, lumbago due to renal deficiency, gastrofrigid vomiting, coldness and pain in the epigastrium.[usage and consumption] 3 ~ 6g.
Rhizoma Chuanxiong, this product is the dry rhizome of samphire Rhizoma Chuanxiong LigusticumchuanxiongHort..[nature and flavor with return through] are pungent, temperature.Return liver, gallbladder, pericardium channel.[function with cure mainly] blood-activating and qi-promoting, wind-expelling pain-stopping.For obstruction of qi in the chest and cardialgia, the twinge of the breast side of body, tumbling and swelling, menoxenia, amenorrhea dysmenorrhea, abdominal mass abdominal mass is suffered from abdominal pain, headache, rheumatic arthralgia.[usage and consumption] 3 ~ 10g.
Concha Meretricis Seu Cyclinae, this product is the shell of Veneridae animal Conch Meretricis seu Cyclinae MeretrixmeretrixLinnaeus or Concha Meretricis Seu Cyclinae CyclinasinensisGmelin.[nature and flavor with return through] are bitter, salty, cold.Return lung, kidney, stomach warp.[function with cure mainly] removing heat-phlegm, hard masses softening and resolving, relieving gastric hyperacidity to alleviate stomachache; External removing dampness sore.For phlegm-fire cough, pain in chest and hypochondrium, sputum mixed with blood, scrofula goiter, stomachache acid regurgitation; External treatment eczema, scalds.[usage and consumption] 6 ~ 15g, be decocted first, Pulvis concha Mactrae is decocted a drug wrapped.Suitable amount used externally, grinds impalpable powder spreading or rear deposited affected part adjusted by oil.
Radix Bupleuri, this product is the dry root of umbelliferae bupleurum BupleurumchinenseDC. or Radix Bupeuri Scorzonerfolii. BupleurumscorzonerifoliumWilld..[nature and flavor with return through] are pungent, bitter, are slightly cold.Return liver, gallbladder, lung meridian.[function with cure mainly] is evacuated and is brought down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.For cold, fever, alternate attack of chill and fever, distending pain in the chest and hypochondrium, menoxenia, uterine prolapse, proctoptosis.[usage and consumption] 3 ~ 10g.
Medulla Junci, this product is the dry stem pith of rush family plant Medulla Junci JuncuseffusesL..[process of preparing Chinese medicine] Medulla Junci removing impurity, the section of cutting.Burnt MEDULLA JUNCI gets clean Medulla Junci, according to charcoal (calcined) method (appendix II D) charcoal processing.This product is in carefully columniform section.Surface black.Body is light, and matter is crisp, frangible.Feeble QI, taste is micro-puckery.[nature and flavor with return through] are sweet, light, are slightly cold.GUIXIN, lung, small intestine meridian.[function with cure mainly] clearing away heart-fire, diuresis.For vexed insomnia, the puckery pain of oliguria, aphtha of the mouth and tongue.[usage and consumption] 1 ~ 3g.
Flos Albiziae, this product is dry inflorescence or the alabastrum of leguminous plant Herba Albiziae AlbiziajulibrissinDurazz..[nature and flavor with return through] are sweet, flat.GUIXIN, Liver Channel.[function with cure mainly] resolving stagnation for tranquilization.For irritability, melancholy insomnia.[usage and consumption] 5 ~ 10g.
Folium Et Cacumen Murrayae, this product is dried leaves and the band leaf twig of rutaceae Folium Et Cacumen Murrayae MurrayaexoticaL. and Murraya paniculata (L.) Jack. Murrayapaniculata (L.) Jack.[process of preparing Chinese medicine] removing impurity, chopping.[nature and flavor] pungent, micro-hardship, temperature; Slightly poisonous.Return liver, stomach warp.[function with cure mainly] promoting the circulation of QI to relieve pain, promoting blood circulation to remove blood stasis.For stomachache, rheumatic arthralgia; External treatment is had a toothache, tumbling and swelling, worm venom.[usage and consumption] 6 ~ 12g.
Arillus Longan, this product is the aril of sapindaceous plant Arillus Longan DimocarpuslonganLour..[nature and flavor with return through] are sweet, temperature.GUIXIN, spleen channel.[function with cure mainly] invigorating the heart and spleen, nourishing blood to tranquillize the mind.For insufficiency of vital energy and blood, severe palpitation, forgetful insomnia, blood deficiency and yellow complexion.[usage and consumption] 9 ~ 15g.
Flos Rosae Rugosae, this product is the dry flower of rosaceous plant Flos Rosae Rugosae RosarugosaThunb..[nature and flavor with return through] sweet, micro-hardship, temperature.Return liver, spleen channel.[function with cure mainly] promoting QI circulation for relieving depression, and blood, pain relieving.For stomachache due to hyperactive liver-QI attacking the stomach, lack of appetite vomiting and nausea, menstruation is not withered, and falls and flutters the pain of injury.[usage and consumption] 3 ~ 6g.
Fructus Ligustri Lucidi, this product is the dry mature fruit of Oleaceae plants Fructus Ligustri Lucidi LigustrumlucidumAit..[nature and flavor with return through] sweet, bitter, cold.Return liver, kidney channel.[function with cure mainly] nourishing the liver and kidney, improving eyesight black hair.For the hepatic and renal YIN deficiency, dizzy ear toot, soreness of the waist and knees, early whitening of beard and hair, poor vision, interior-heat is quenched one's thirst, osteopyrexia and fever.[usage and consumption] 6 ~ 12g.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine for the treatment of hysteromyoma, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing hysteromyoma.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of Chinese medicine for the treatment of hysteromyoma, it is characterized in that, it is prepared from by the medical material of following weight proportion: Fructus Anisi Stellati 3 ~ 6 parts, Rhizoma Chuanxiong 3 ~ 10 parts, Concha Meretricis Seu Cyclinae 6 ~ 15 parts, Radix Bupleuri 3 ~ 10 parts, Medulla Junci 1 ~ 3 part, Flos Albiziae 5 ~ 10 parts, Folium Et Cacumen Murrayae 6 ~ 12 parts, Arillus Longan 9 ~ 15 parts, Flos Rosae Rugosae 3 ~ 6 parts, Fructus Ligustri Lucidi 6 ~ 12 parts.
Wherein preferred: Fructus Anisi Stellati 4 parts, Rhizoma Chuanxiong 6 parts, Concha Meretricis Seu Cyclinae 12 parts, Radix Bupleuri 8 parts, Medulla Junci 2 parts, Flos Albiziae 8 parts, Folium Et Cacumen Murrayae 10 parts, Arillus Longan 12 parts, Flos Rosae Rugosae 4 parts, Fructus Ligustri Lucidi 8 parts.
Below in conjunction with theory of Chinese medical science, the beneficial effect that we are bright is described:
Inventor thinks, mostly hysteromyoma is because internal injury caused by excess of seven emotions, visceral dysfunction, qi depression to blood stasis form.Therefore depressed liver-energy dispersing and QI regulating, nourishing spleen kidney, blood circulation promoting and blood stasis dispelling are answered in treatment.The present invention uses Fructus Anisi Stellati warming YANG to regulate the flow of vital energy; Fructus Ligustri Lucidi nourishing the liver and kidney; Radix Bupleuri, Medulla Junci, Flos Albiziae, Flos Rosae Rugosae dispersing the stagnated live-QI to relieve the stagnation of QI are calmed the nerves; Arillus Longan invigorating the heart and spleen; Rhizoma Chuanxiong, Folium Et Cacumen Murrayae promoting flow of QI and blood dissipating blood stasis; Concha Meretricis Seu Cyclinae resolving phlegm and softening hard masses eliminating stagnation.All medicines share, thus heat-clearing and toxic substances removing, removing heat from blood suppressing the hyperactive liver, treatment hysteromyoma.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects the outpatients of gynecology of 75 patients with uterin leiomyomas-2010 years in October, 2007 altogether between JIUYUE, age 26-48 year, the course of disease 1-3 year.Be divided at random: treatment group 50 example, matched group 25 example.Two groups of data there was no significant differences such as the course of disease, age, have comparability.
2, test method
2.1 Therapeutic Method
The oral danazol of matched group, takes according to its description.1 month course for the treatment of.
The capsule that the oral the present invention for the treatment of group obtains according to specific embodiment 1, every day 2 times.1 month course for the treatment of.
2.2 observation items: menoxenia before and after patient treatment, abdominal part are swollen and accompany bearing down, leucorrhea is many and accompanies the symptoms such as abnormal flavour, lower abdomen falling inflation, aching pain in waist and back to carry out observed and recorded.Laboratory ultrasound diagnosis Uterine Leiomyoma situation.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, the atrophy of ultrasound diagnosis hysteromyoma.Take a turn for the better: clinical symptom relief, ultrasound diagnosis hysteromyoma diameter diminishes or not regrowth.Invalid: clinical symptoms is without being clearly better or increasing the weight of, and ultrasound diagnosis hysteromyoma continues to grow up.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
Group n Recovery from illness Take a turn for the better Invalid Untoward reaction example Total effective rate (%)
Treatment group 50 42 6 2 0(0%) 96%
Matched group 25 3 20 2 16(64%) 92%
Visible, the medicine that the preferred embodiment for the present invention obtains can safe and effective treatment hysteromyoma.
According to above-mentioned clinical laboratory data, the Chinese medicine Analysis on Mechanism of hysteromyoma and general knowledge known in this field is treated in conjunction with the present invention, those skilled in the art easily know by inference, use the medical material in the present invention, value near optimum weight part, at least " Fructus Anisi Stellati 3 ~ 6 parts, Rhizoma Chuanxiong 3 ~ 10 parts, Concha Meretricis Seu Cyclinae 6 ~ 15 parts, Radix Bupleuri 3 ~ 10 parts, Medulla Junci 1 ~ 3 part, Flos Albiziae 5 ~ 10 parts, Folium Et Cacumen Murrayae 6 ~ 12 parts, Arillus Longan 9 ~ 15 parts, Flos Rosae Rugosae 3 ~ 6 parts, Fructus Ligustri Lucidi 6 ~ 12 parts " scope in, the technique effect that the medicine that obtains with the preferred embodiment for the present invention is similar can be obtained.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take Fructus Anisi Stellati 4g, Rhizoma Chuanxiong 6g, Concha Meretricis Seu Cyclinae 12g, Radix Bupleuri 8g, Medulla Junci 2g, Flos Albiziae 8g, Folium Et Cacumen Murrayae 10g, Arillus Longan 12g, Flos Rosae Rugosae 4g, Fructus Ligustri Lucidi 8g; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell, the capsule of adult normal's one day consumption must be met.
Be used for the treatment of hysteromyoma.Oral, every bu is taken for twice sooner or later.
Embodiment 2
Take Fructus Anisi Stellati 3g, Rhizoma Chuanxiong 3g, Concha Meretricis Seu Cyclinae 6g, Radix Bupleuri 3g, Medulla Junci 1g, Flos Albiziae 5g, Folium Et Cacumen Murrayae 6g, Arillus Longan 9g, Flos Rosae Rugosae 3g, Fructus Ligustri Lucidi 6g; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of hysteromyoma.Oral, once a day.
Embodiment 3
Take Fructus Anisi Stellati 6g, Rhizoma Chuanxiong 10g, Concha Meretricis Seu Cyclinae 15g, Radix Bupleuri 10g, Medulla Junci 3g, Flos Albiziae 10g, Folium Et Cacumen Murrayae 12g, Arillus Longan 15g, Flos Rosae Rugosae 6g, Fructus Ligustri Lucidi 12g; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, then adds appropriate dextrin and correctives, granulates according to this area common process, and packaging, can obtain the granule meeting adult normal's one day consumption.
Be used for the treatment of hysteromyoma.Oral, every bu morning, noon and afternoon take for three times.

Claims (2)

1. treat the Chinese medicine of hysteromyoma for one kind, it is characterized in that, it is prepared from by the medical material of following weight proportion: Fructus Anisi Stellati 3 ~ 6 parts, Rhizoma Chuanxiong 3 ~ 10 parts, Concha Meretricis Seu Cyclinae 6 ~ 15 parts, Radix Bupleuri 3 ~ 10 parts, Medulla Junci 1 ~ 3 part, Flos Albiziae 5 ~ 10 parts, Folium Et Cacumen Murrayae 6 ~ 12 parts, Arillus Longan 9 ~ 15 parts, Flos Rosae Rugosae 3 ~ 6 parts, Fructus Ligustri Lucidi 6 ~ 12 parts.
2. according to the Chinese medicine for the treatment of hysteromyoma according to claim 1, it is characterized in that, it is prepared from by the medical material of following weight proportion: Fructus Anisi Stellati 4 parts, Rhizoma Chuanxiong 6 parts, Concha Meretricis Seu Cyclinae 12 parts, Radix Bupleuri 8 parts, Medulla Junci 2 parts, Flos Albiziae 8 parts, Folium Et Cacumen Murrayae 10 parts, Arillus Longan 12 parts, Flos Rosae Rugosae 4 parts, Fructus Ligustri Lucidi 8 parts.
CN201310605613.3A 2013-11-26 2013-11-26 A kind of Chinese medicine for the treatment of hysteromyoma Active CN103599271B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310605613.3A CN103599271B (en) 2013-11-26 2013-11-26 A kind of Chinese medicine for the treatment of hysteromyoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310605613.3A CN103599271B (en) 2013-11-26 2013-11-26 A kind of Chinese medicine for the treatment of hysteromyoma

Publications (2)

Publication Number Publication Date
CN103599271A CN103599271A (en) 2014-02-26
CN103599271B true CN103599271B (en) 2015-09-16

Family

ID=50117577

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310605613.3A Active CN103599271B (en) 2013-11-26 2013-11-26 A kind of Chinese medicine for the treatment of hysteromyoma

Country Status (1)

Country Link
CN (1) CN103599271B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288486A (en) * 2015-11-26 2016-02-03 宋妮妮 Uterine fibroid treating traditional Chinese medicine composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101912585A (en) * 2010-08-27 2010-12-15 葛德钜 Medicament for treating myoma of uterus and preparation method thereof
CN102120020A (en) * 2011-03-10 2011-07-13 雷允上药业有限公司 Medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and preparation method thereof
CN102727673A (en) * 2012-02-24 2012-10-17 广州加原医药科技有限公司 Chinese medicine composition for treating hysteromyoma and preparation method thereof
CN103285291A (en) * 2013-06-18 2013-09-11 冯宇伟 Medicine for treating uterine fibroid and ovarian cyst and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101912585A (en) * 2010-08-27 2010-12-15 葛德钜 Medicament for treating myoma of uterus and preparation method thereof
CN102120020A (en) * 2011-03-10 2011-07-13 雷允上药业有限公司 Medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and preparation method thereof
CN102727673A (en) * 2012-02-24 2012-10-17 广州加原医药科技有限公司 Chinese medicine composition for treating hysteromyoma and preparation method thereof
CN103285291A (en) * 2013-06-18 2013-09-11 冯宇伟 Medicine for treating uterine fibroid and ovarian cyst and preparation method thereof

Also Published As

Publication number Publication date
CN103599271A (en) 2014-02-26

Similar Documents

Publication Publication Date Title
CN102000164A (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof
CN105435197A (en) Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof
CN102805834B (en) Drug for curing gastritis and preparation method thereof
CN104758900A (en) Traditional Chinese medicine for treating acute pancreatitis
CN103599271B (en) A kind of Chinese medicine for the treatment of hysteromyoma
CN103638357A (en) Traditional Chinese medicine composition for preventing and treating epidemic meningitis and preparation method thereof
CN103520352B (en) The Chinese medicine for the treatment of stasis blocking venation pattern of syndrome obstruction of qi in the chest and cardialgia
CN105343795A (en) Drug for treating insomnia and preparation method thereof
CN104840773A (en) Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same
CN104666806A (en) Traditional Chinese medicine for treating epidemic meningitis
CN103656199B (en) A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough
CN108853253A (en) A kind of Chinese medicine composition of invigorating kidney, promoting blood circulation and its preparation method and application
CN103520672B (en) The Chinese medicine for the treatment of dampness-heat of the liver pattern of syndrome menopathy
CN103720871B (en) Medicine for treating acne rosacea and preparation method thereof
CN106110167A (en) One treats lipomatous Chinese medicine composition and preparation method thereof
CN105943924A (en) Traditional Chinese medicine for treating gallbladder fire exuberance syndrome type multiple gall-stone
CN104740364A (en) Traditional Chinese medicine for treating dizziness diseases caused by hyperactivity of liver-yang
CN104645112A (en) Nasopharyngeal carcinoma hard mass softening and phlegm eliminating preparation and preparation method thereof
CN104258032A (en) Traditional Chinese medicine composition for treating stomach cancer
CN104666811A (en) Preparation method of pepsin treated APR (Anemarrhena, Phellodendrom and Rehmannia) oral liquid
CN103566052B (en) A kind of Chinese medicine for the treatment of thyroid tumor
CN103505713B (en) Traditional Chinese medicine formula for treating disharmony between ying and wei syndrome muscle numbness disease
CN103463222B (en) A kind of Chinese medicine composition for the treatment of dysentery
CN105535693A (en) Medicine composition for treating senile wind-yang nuisance type dizziness and preparation method thereof
CN105521225A (en) Traditional Chinese medicinal composition for boosting immunity and preparation method of traditional Chinese medicinal composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Ren Xinnian

Inventor after: Sun Yuansheng

Inventor before: Sun Yuansheng

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: SUN YUANSHENG TO: REN XINNIAN SUN YUANSHENG

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20171023

Address after: The 400000 northern New District of Chongqing municipality Mount Huangshan Middle Road No. 66 A207

Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd.

Address before: 325200 horses in Zhejiang province Ruian city Wenzhou city Yu Zhen Jiang Village

Patentee before: Sun Yuansheng

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20171116

Address after: 401120 Chongqing Longxi street, California city garden, Yubei District, 3, 8-5

Patentee after: CHONGQING FANCHAO BRAND MANAGEMENT CO., LTD.

Address before: The 400000 northern New District of Chongqing municipality Mount Huangshan Middle Road No. 66 A207

Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190604

Address after: 221600 South Side of No.1 Road, Peixian Industrial Park, Xuzhou City, Jiangsu Province

Patentee after: Jiangsu Guilong Biological Technique Co., Ltd.

Address before: 401120 Chongqing Yubei District Longxi Street 3 California City Garden 8-5

Patentee before: CHONGQING FANCHAO BRAND MANAGEMENT CO., LTD.

TR01 Transfer of patent right